Connect Biopharma News

Connect Biopharma | 20-F: Registration statement / Annual report / Transition report

Apr 16 17:06 ET

Connect Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 16 16:26 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Panacea Innovation Limited(21.8%),Panacea Venture Healthcare Fund II, L.P.(21.8%), etc.

Feb 27 21:02 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.

Feb 27 16:28 ET

Connect Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%), etc.

Feb 13 16:38 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wubin Pan(12.1%),BioFortune Inc(11.2%)

Feb 13 16:32 ET

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Zheng Wei(11.7%)

Feb 13 16:29 ET

Connect Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 12 16:56 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(5.6%),Peter Kolchinsky(5.6%), etc.

Dec 20, 2023 16:30 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 18, 2023 18:44 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 18, 2023 18:09 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.3%),Peter Kolchinsky(9.3%), etc.

Dec 14, 2023 16:30 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 12, 2023 19:40 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 12, 2023 19:05 ET

Connect Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 12, 2023 06:10 ET

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(10.8%),Peter Kolchinsky(10.8%), etc.

Dec 4, 2023 17:20 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 27, 2023 19:49 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 27, 2023 19:32 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21, 2023 19:09 ET

Connect Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21, 2023 18:58 ET